Purchase Order HHSD2002015M63736P

This is a $11,590 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) to Peptide 2.0 Inc., a minority-owned small business, for the provision of custom peptides. The contract has a period of performance ending on March 25, 2015. Peptide 2.0 Inc., also doing business as Peptide 20 Inc., is a for-profit organization that specializes in custom peptide synthesis, production, and research, and has received several previous contract awards from the NIH and the U.S....

The U.S. government awarded Genscript USA Inc. a $6,582.14 firm fixed-price purchase order on September 12, 2016, for custom peptide synthesis and purification services. The contract, with an ultimate completion date of October 14, 2016, was funded by a civilian agency within the Pacific West Area and performed at the vendor's facility in Piscataway, New Jersey. No small business set-aside designation was applied to this award. Genscript USA Inc. is a biotechnology company specializing in...

The National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), has awarded a $17,950 firm fixed-price purchase order to Polypeptide Laboratories San Diego, LLC (Polypeptide Labs) for a storage and stability study of drug substances and products. This contract, which has an ultimate completion date of July 31, 2025, does not have a set-aside designation. Polypeptide Labs is a specialized manufacturer of peptides and related compounds,...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $28,000 firm fixed price purchase order to Karebay Biochem Inc. under request for quotes RFQ-NIAID-23-2175814. The contract calls for the delivery of a peptide library consisting of 408 peptides, each with 1 milligram of a 15 amino acid peptide at 95% purity. The place of performance is China. The award was set aside for total small business and will...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Peprotech Inc., a privately-owned biotechnology company. The $4,205 contract is for the delivery of drugs and biologicals, with a performance period ending on September 16, 2012. Peprotech Inc. is a manufacturer of cytokines and other biological products, and has received several prior federal contract awards from...

This delivery order, awarded August 1, 2025, to AmerisourceBergen Drug Corp provides Protamine 50 mg/5 mL vials with a ceiling value of $1,078.10 and a completion date of August 4, 2025. The award was made without a set-aside designation through a competitive process by the Defense Logistics Agency's Medical Supply Chain on behalf of the Defense Department. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its...

The Defense Logistics Agency Troop Support Medical awarded a $209,300 delivery order to Pfizer Inc. for hydrocortisone sodium succinate, 125mg/mL. Pfizer will deliver the pharmaceutical product from its New York location by July 31, 2023 to support DLA's medical supply chain activities. As the prime contractor, Pfizer will be responsible for fulfilling the agency's requirements for this corticosteroid medication over the one-week performance period of the firm fixed price contract. No...

Fresenius Kabi, LLC has been awarded a delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide approximately $675 in protamine sulfate injection USP 50mg single-dose vials. The Defense Logistics Agency will utilize this product delivery from Fresenius Kabi's Lake Zurich, Illinois facility to support its medical supply needs between July 27 and August 1, 2023. The firm fixed price order was competitively awarded without...

The Defense Logistics Agency awarded a $21,803 delivery order to Amerisourcebergen Drug Corporation for PHESGO, a fixed-dose combination of recombinant human hyaluronidase and two oncology monoclonal antibodies. Performance will take place in Conshohocken, Pennsylvania under firm fixed pricing from September 20th through October 12th of this year. No set-aside designation or subcontractors were indicated. This order is likely in support of the DLA's stockpile of pharmaceuticals for treating...

<p>The Defense Logistics Agency's Medical Supply Chain division issued a purchase order to Bausch &amp; Lomb Incorporated on February 11, 2026, for hydroxypropyl methylcellulose valued at $3,135.60 on a firm fixed-price basis. No set-aside applies. Place of performance is Rochester, New York. The order is due for completion by February 18, 2026.</p>